Sickle cell drug voxelotor tested for physical boost in small trial
NCT ID NCT06023199
First seen Dec 26, 2025 · Last updated May 19, 2026 · Updated 22 times
Summary
This study looks at whether voxelotor, a drug that helps red blood cells stay healthy, can improve physical function in adults with sickle cell disease. Six participants will take the drug for 6 months and have their walking ability tested. The goal is to see if the drug helps them move better and feel stronger.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Inova Schar Cancer Institute
Falls Church, Virginia, 22042, United States
Conditions
Explore the condition pages connected to this study.